Form 4: Exponent CEO Catherine Corrigan Executes Stock Options
Statement of Changes in Beneficial Ownership
Exponent CEO Catherine Corrigan exercised stock options and sold shares to cover tax obligations and exercise costs.
Summary
- CEO Catherine Corrigan exercised options for 3,225 shares at $25.405 and 2,380 shares at $29.05.
- A total of 4,119 shares were sold at an average price of $57.1263 to cover exercise costs and tax liabilities.
- Following these transactions, the CEO maintains a direct beneficial ownership of 107,257 shares of Exponent common stock.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event, as the transactions are routine administrative actions related to executive compensation and tax obligations.
Positives
- The transaction was executed under a pre-planned Rule 10b5-1 trading plan, indicating systematic rather than discretionary selling.
- The CEO retains a significant equity stake of 107,257 shares, aligning interests with shareholders.
Negatives
- The sale of shares, even for tax purposes, reduces the total direct holdings of the CEO.
Risks
- Future stock price volatility could impact the value of remaining unexercised options.
Future Outlook
No forward-looking guidance regarding company performance was provided in this filing.
Industry Context
StockSavvy.ai notes that routine insider selling to cover tax obligations upon option exercise is a standard corporate governance practice and typically does not signal a change in management sentiment regarding company prospects.
Comparison to Industry Standards
- The use of Rule 10b5-1 plans is considered a best practice for executives to avoid potential conflicts of interest regarding insider trading regulations.
Stakeholder Impact
- Minimal impact on shareholders as the transactions were pre-planned and related to tax obligations.
Next Steps
- No further actions or milestones were disclosed in this filing.
Key Dates
| Date | Description |
|---|---|
| 06/15/2026 | Date of option exercise and subsequent share sales. |
| 06/17/2026 | Date of filing for the reported transactions. |
Keywords
Exponent, EXPO, Insider Trading, Form 4, Executive Compensation, Stock Options
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.